vTv Therapeutics (VTVT)
(Delayed Data from NSDQ)
$13.13 USD
-0.22 (-1.65%)
Updated Sep 27, 2024 02:23 PM ET
After-Market: $13.86 +0.73 (5.56%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
vTv Therapeutics Inc. [VTVT]
Reports for Purchase
Showing records 1 - 20 ( 44 total )
Company: vTv Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: vTv Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Azeliragon Receives FDA Approval For Clinical Trials in Glioblastoma and Brain Metastases; Reiterate Buy and $6 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: vTv Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Expecting New Leadership and Partnership to Accelerate TTP399 Pivotal Study; Reiterate Buy and $6 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: vTv Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
TP399 Phase 3 Trials on Track for 4Q22; Reiterate Buy and $6 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: vTv Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
TTP399 Represents an Attractive Licensing Opportunity; Reiterate Buy and $6 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: vTv Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: vTv Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
TTP399 on Track to Begin Phase 2 Study in Early 2022; Reit Buy and $6 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: vTv Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Company: vTv Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Positive Results Position HPP737 on Track to Begin Phase 2 Study in Early 2022; Reit Buy and $6 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: vTv Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Productive FDA Meeting Sets Pivotal Path for TTP399 in Motion; Reiterate Buy and $6 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: vTv Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Broad Clinical Progress Demonstrated in 1Q21; Reiterate Buy and $6 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: vTv Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Mechanistic Study Initiated to Evaluate TTP399?s Effects on Diabetic Ketoacidosis
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: vTv Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Energy Rich Alberta Opens Runways for a Miner Carefully Governing its Bitcoin Holdings; Initial Coverage: Buy, C$14
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: vTv Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Licensing Agreement Announced for Novel Nrf2 Activator HPP971 with Anteris Bio
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: vTv Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Characteristics of Patients in Elevage Suggest the Phase 2/3 is STEADFAST; Reiterate Buy and $6 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: vTv Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
Mechanism of Action Matters, So TTP399 May Be Better for Your Diabetes; Reiterate Buy and $6 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: vTv Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
2Q20 Results and TTP399 Simplici-T1 Phase 2 Data in T1D; Reiterate Buy and $6 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: vTv Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
TTP399 Still Simply Our Main Focus Near-Term; Reiterate Buy and $6 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: vTv Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
TTP399 Simply the Highlight of Momentum Going Into 2020; Reiterate Buy and $6 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: vTv Therapeutics Inc.
Industry: Medical - Biomedical and Genetics
TTP399 May Simply Be a Breakthrough in T1D Treatment; Reiterate Buy With a New $6 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V